# Anakinra as a Rescue Treatment for Allergic Inflammation

> **NCT04035109** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Asthma, Allergic

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Preservative-free 0.9% sodium chloride (Placebo)
- **BIOLOGICAL:** House dust mite allergen
- **BIOLOGICAL:** Cat hair allergen

## Key facts

- **NCT ID:** NCT04035109
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-16
- **Primary completion:** 2022-10
- **Final completion:** 2023-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to COVID-19 pandemic.
- **Last updated:** 2022-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04035109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04035109, "Anakinra as a Rescue Treatment for Allergic Inflammation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04035109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*